scispace - formally typeset
Open AccessJournal ArticleDOI

Vectored expression of the broadly neutralizing antibody FI6 in mouse airway provides partial protection against a new avian influenza A virus, H7N9.

Reads0
Chats0
TLDR
H7N9 is currently contained in Southeastern China, and the majority of human cases of infection have reported direct exposure to poultry, while no fatalities have been reported.
Abstract
As of 4 July 2013, there have been 134 confirmed cases of human infection and 43 fatalities with a new avian influenza A virus (H7N9) ([1][1]). H7N9 is currently contained in Southeastern China, and the majority of human cases of infection have reported direct exposure to poultry ([2][2]). While no

read more

Citations
More filters
Journal ArticleDOI

Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy

TL;DR: It is demonstrated that simple intramuscular delivery by electroporation of synthetic DNA plasmids engineered to express modified human nAbs against multiple DENV serotypes confers protection against DENV disease and prevents antibody-dependent enhancement of disease in mice.
Journal ArticleDOI

In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies

TL;DR: This review focuses on nucleic acid delivery of antibody employing synthetic plasmid DNA vector platforms, and RNA delivery, these being important approaches that are advancing simple, rapid, in vivo expression and having an impact in animal models of infectious diseases and cancer, among others.
Journal ArticleDOI

Adeno-associated virus 9-mediated airway expression of antibody protects old and immunodeficient mice against influenza virus.

TL;DR: It is proposed that airway-directed AAV9 passive immunization against airborne infectious agents may be beneficial in elderly and immunocompromised patients, for whom there still exists an unmet need for effective vaccination against influenza.
Journal ArticleDOI

Genetic Modification of the Lung Directed Toward Treatment of Human Disease

TL;DR: More work is still needed to improve the delivery vehicles and to overcome challenges such as entry barriers, persistent expression, specific cell targeting, and circumventing host anti-vector responses.
References
More filters
Related Papers (5)